CytomX Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CTMX-US : April 5, 2016

*Disclaimer : This is as of previous day’s closing price.

Technical Indicators

Below is a quick look at 5 technical indicators for CytomX Therapeutics, Inc.. More studies are available on the Technical Chart.

Indicator Signal
Closing Price above/below 50 Day Moving Average Bullish
Closing Price above/below 200 Day Moving Average Bullish
50 Day Moving Average above/below 200 Day Moving Average Bullish
RSI Reading Level (<30 or >70) Bullish
MACD Compared to 9D EMA Signal Line Bullish

View these and more technical studies for CytomX Therapeutics, Inc.

Share Price Performance Relative to Peers

CTMX-US has traded publicly for less than a year.

CTMX-US‘s shares have traded publicly for less than a year. Over the last one month, however, the company’s share price has relatively underperformed with a return of -0.44% vs. peer median of 7.54%.

Screen for companies using relative share price performance

Earnings Momentum

CytomX Therapeutics, Inc. has an earnings score of 38.76 and has a relative valuation of OVERVALUED.

Stocks with High Earnings Momentum are a preferred option for momentum plays. If they are undervalued, it can be a further advantage and may indicate sustained momentum.

Earnings Momentum Vs Relative Valuation

Quadrant label definitions. Hover to know more

Overvalued, High Earnings Momentum, Undervalued, High Earnings Momentum, UnderValued, Low Earnings Momentum, Overvalued, Low Earnings Momentum

Screen for companies using Earnings Momentum Score

Leave a Comment